Form 13-F position report

GOSSAMER BIO INC COM (DE)

Reported by Opaleye Management Inc

GOSS CUSIP 38341P102 Manager CIK 0001595855

Reported 2,440,109 shares, down 542,091 (18.2%) from the prior quarter.

Reported value 5.8%; share count -18.2% vs. the prior quarter.

Reduced
% of reported 13F value 0.63% This manager · Q1 2024
Shares 2,440,109 Quarter-end amount reported
Reported value $2,879,329 Fair value at quarter end
Consecutive quarters held 4 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 4044000
2023-09-30 3959298
2023-12-31 2721258
2024-03-31 2879329
2024-06-30 3522519
2024-09-30 3705692
2024-12-31 4061654
2025-03-31 4716157
2025-06-30 4360350
2025-09-30 7166750
2025-12-31 8432000
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for GOSSAMER BIO INC COM (DE) held by Opaleye Management Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -2,720,000 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 2,720,000 -5,000 (-0.2%) 1.11% $8,432,000 2026-02-17
Q3 2025 Reduced 2,725,000 -820,000 (-23.1%) 1.01% $7,166,750 2025-11-14
Q2 2025 Reduced 3,545,000 -742,415 (-17.3%) 0.88% $4,360,350 2025-08-14
Q1 2025 Reduced 4,287,415 -202,585 (-4.5%) 1.05% $4,716,157 2025-05-15
Q4 2024 Added 4,490,000 +824,990 (22.5%) 0.71% $4,061,654 2025-02-14
Q3 2024 Reduced 3,665,010 -244,990 (-6.3%) 0.62% $3,705,692 2024-11-14
Q2 2024 Added 3,910,000 +1,469,891 (60.2%) 0.8% $3,522,519 2024-08-14
Q1 2024 Reduced 2,440,109 -542,091 (-18.2%) 0.63% $2,879,329 2024-05-15
Q4 2023 Reduced 2,982,200 -1,772,000 (-37.3%) 0.72% $2,721,258 2024-02-14
Q3 2023 Added 4,754,200 +1,384,200 (41.1%) 1.29% $3,959,298 2023-11-15
Q2 2023 New 3,370,000 +3,370,000 (0.0%) 0.97% $4,044,000 2023-08-14

Who else reported the position

126 managers reported GOSSAMER BIO INC COM (DE) for Q1 2024.

Managers reporting GOSSAMER BIO INC COM (DE) in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 15,838,009 0 1.16% $18,688,851 7 qtrs
Artal Group S A Added 13,308,968 +1,250,000 0.4% $15,704,582 21 qtrs
VANGUARD GROUP INC Added 11,763,784 +128,150 < 0.01% $13,881,265 21 qtrs
EcoR1 Capital LLC Unchanged 9,195,404 0 0.27% $10,850,577 3 qtrs
Octagon Capital Advisors LP Unchanged 9,187,883 0 1.3% $10,841,702 14 qtrs
FMR LLC Reduced 8,189,147 -4,074,771 < 0.01% $9,663,194 21 qtrs
ARCH Venture Management LLC Unchanged 8,055,916 0 11.84% $9,505,981 3 qtrs
MILLENNIUM MANAGEMENT LLC Added 6,495,420 +2,270,810 < 0.01% $7,664,596 18 qtrs
Palo Alto Investors LP Added 6,391,775 +432,887 0.85% $7,542,295 16 qtrs
FARALLON CAPITAL MANAGEMENT LLC Unchanged 6,130,272 0 0.03% $7,233,721 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,440,109
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.